Clinical variation in Lowe syndrome: what and how?

Area of Science:

• Biochemistry
• Genetics
• Pediatrics

Background:

• Lowe syndrome is an X-linked disorder caused by mutations in the OCRL gene, affecting the inositol polyphosphate-5-phosphatase OCRL (Ocrl1) enzyme.
• Ocrl1 is expressed in nearly all body cells, contributing to the wide range of clinical manifestations observed in patients.

Purpose of the Study:

• To explore the complex genotype-phenotype correlations in Lowe syndrome.
• To highlight the challenges in predicting disease severity due to ubiquitous Ocrl1 expression and functional complexity.
• To emphasize the potential of understanding molecular abnormalities for developing targeted therapies.

Main Methods:

• Review of clinical characteristics and genetic mutations associated with Lowe syndrome.
• Analysis of genotype-phenotype variability within families.
• Discussion of ongoing research into Ocrl1 variants and cell phenotype models.

Main Results:

• Lowe syndrome presents with heterogeneous phenotypes affecting kidneys, brain, eyes, and other organs.
• All patients develop chronic kidney disease, and most exhibit neurological and ocular abnormalities.
• Establishing a clear genotype-phenotype correlation is challenging due to disease complexity.

Conclusions:

• Despite being a monogenic disorder, Lowe syndrome exhibits significant clinical heterogeneity.
• Further research into Ocrl1 molecular function and variants is crucial for developing predictive models and therapeutic strategies.
• Understanding genotype-phenotype relationships can lead to personalized treatment approaches for Lowe syndrome patients.